Skip to content

US · USPH · MEDICAL - CARE FACILITIES

U.S. Physical Therapy, Inc. (USPH) intrinsic value and stock valuation

$95.93as of 2026-11-21 · Mkt cap 1.18B

Data updated · price as of 2026-11-21

Fairly valuedIC value is within 20% of the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

U.S. Physical Therapy, Inc. DCF and intrinsic value

InvestorsCraft values USPH with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from USPH’s statements →

U.S. Physical Therapy, Inc. Graham Number

Graham Number: $33.65d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Healthcare · Medical - Care Facilities Houston, TX 77042 usph.com

How the business is doing

Fiscal 2011–2025, USD

Revenue
$781M+13% 5y CAGRd
20112025
Net income
$15.1M-13.2% 5y CAGRd
20112025
Free cash flow
$61M-8% 5y CAGRd
20112025
Total equity
$769.7M+13.4% 5y CAGRd
20112025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2011–2025, USD
20252024202320222021
Revenue$781M$671.4M$604.8M$553.1M$495M
Operating income$80.4M$63.2M$52.1M$56.8M$70.7M
Net income$15.1M$26.5M$14.7M$28.3M$27.8M
EPSd$992.1K$1.76M$1.03M$2.18M$2.16M
Operating cash flow$75.1M$74.9M$82M$58.5M$76.4M
Capital expenditure-$-14.07M-$-9.19M-$-9.29M-$-8.25M-$-8.2M
Free cash flow$61M$65.8M$72.7M$50.3M$68.2M
Total assets$1.2B$1.17B$997.2M$858.2M$749.4M
Total debt$425.7M$295.2M$258.6M$295.3M$223.1M
Net debt$390.2M$253.9M$105.8M$263.7M$194.5M
Total equity$769.7M$759.1M$652.2M$484.6M$452.4M
Cash and short-term investments$35.6M$41.4M$152.8M$31.6M$28.6M
Income statement
20252024202320222021
Revenue$781M$671.4M$604.8M$553.1M$495M
Cost of revenue$623.7M$547.4M$483.3M$441.1M$377.8M
Gross profit$157.3M$123.9M$121.5M$112M$117.2M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$0.00$58.3M$0.00$46.1M$46.5M
Other expenses$76.9M$2.42M$69.5M$9.11M$0.00
Operating expenses$76.9M$60.7M$69.5M$55.2M$46.5M
Cost and expenses$700.6M$608.1M$552.7M$496.3M$424.4M
Interest income$100K$3.94M$3.77M$0.00$0.00
Interest expense$9.46M$8.02M$9.3M$5.78M$940K
Depreciation and amortization$22.4M$18.7M$15.7M$14.7M$11.6M
Ebitda$109.7M$86.9M$74.4M$76.1M$85.7M
Operating income$80.4M$63.2M$52.1M$56.8M$70.7M
Total other income/expenses, net-$-2.62M-$-3M-$-2.69M-$-1.23M$2.55M
Income before tax$77.8M$60.2M$49.4M$55.6M$73.2M
Income tax expense$19.8M$14.6M$12.2M$12.2M$15.3M
Net income$15.1M$26.5M$14.7M$28.3M$27.8M
Weighted average shares outstanding$15.2M$15.1M$14.2M$13M$12.9M
Weighted average diluted shares outstanding$15.2M$15.1M$14.2M$13M$12.9M
Balance sheet
20252024202320222021
Cash and short-term investments$35.6M$41.4M$152.8M$31.6M$28.6M
Net receivables$88.3M$85.7M$69.7M$69.3M$62.4M
Inventory$0.00$0.00$0.00$0.00$0.00
Total current assets$140M$137.6M$233.4M$111.3M$95.2M
Property, plant and equipment, net$271.1M$166.1M$129.5M$127.8M$119.4M
Goodwill and intangible assets$865.3M$846.5M$619.3M$602.9M$521.1M
Long-term investments$12.3M$12.2M$12.3M$12.1M$12.2M
Total non-current assets$1.06B$1.03B$763.9M$746.9M$654.3M
Total assets$1.2B$1.17B$997.2M$858.2M$749.4M
Accounts payable$6.06M$5.94M$3.9M$6.5M$6.47M
Short-term debt$52M$50.8M$42.9M$41.6M$31.3M
Deferred revenue$0.00$0.00$0.00$0.00$0.00
Total current liabilities$139M$116.3M$102.2M$85.5M$83.5M
Long-term debt$373.7M$244.4M$215.6M$253.8M$191.8M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$294.8M$292.1M$242.8M$288.1M$213.5M
Capital lease obligations$110.6M$141.7M$111.9M$111.6M$104.7M
Total liabilities$433.8M$408.4M$345M$373.6M$297M
Common stock$170K$170K$170K$150K$150K
Retained earnings$227.2M$227.3M$223.8M$233M$224.4M
Accumulated other comprehensive income (loss)$710K$2.8M$2.78M$4M-$0.00
Total equity$769.7M$759.1M$652.2M$484.6M$452.4M
Total investments$12.3M$12.2M$12.3M$12.1M$12.2M
Total debt$425.7M$295.2M$258.6M$295.3M$223.1M
Net debt$390.2M$253.9M$105.8M$263.7M$194.5M
Cash flow statement
20252024202320222021
Net income$58M$45.6M$37.2M$43.4M$57.9M
Depreciation and amortization$22.4M$18.7M$15.7M$14.7M$11.6M
Stock-based compensation$8.27M$7.82M$7.24M$7.26M$7.87M
Change in working capital-$-27.19M-$-12.4M-$-4.93M-$-21.43M-$-11.78M
Accounts receivable-$-9.06M-$-11.89M-$-6M-$-10.28M-$-10.96M
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable-$-7.8M$0.00$10K-$-7.75M$0.00
Net cash provided by operating activities$75.1M$74.9M$82M$58.5M$76.4M
Investments in property, plant and equipment-$-14.07M-$-9.19M-$-9.29M-$-8.25M-$-8.2M
Acquisitions, net-$-24.95M-$-142.04M-$-36.87M-$-74.28M-$-116.09M
Net cash used for investing activities-$-36.71M-$-149.45M-$-45.02M-$-81.27M-$-124.14M
Common stock issued$0.00$0.00$163.7M$0.00$0.00
Common stock repurchased-$-5.57M$0.00$0.00$0.00$0.00
Dividends paid-$-27.36M-$-26.54M-$-24.13M-$-21.32M-$-18.77M
Net cash used for financing activities-$-44.14M-$-36.95M$84.3M$25.8M$43.4M
Net change in cash-$-5.79M-$-111.46M$121.2M$3.03M-$-4.35M
Cash at end of period$35.6M$41.4M$152.8M$31.6M$28.6M
Operating cash flow$75.1M$74.9M$82M$58.5M$76.4M
Capital expenditure-$-14.07M-$-9.19M-$-9.29M-$-8.25M-$-8.2M
Free cash flow$61M$65.8M$72.7M$50.3M$68.2M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About U.S. Physical Therapy, Inc.

        U.S. Physical Therapy, Inc., through its various subsidiaries, manages a network of outpatient physical therapy facilities. These clinics deliver a range of services, including rehabilitation before and after surgery, treatment for musculoskeletal conditions, recovery from sports-related trauma, proactive health measures, assistance for workers recovering from injuries, and care for neurological conditions. The company's business is divided into two primary divisions: Physical Therapy Operations and Industrial Injury Prevention Services. Within its industrial segment, it provides specialized services like on-site injury avoidance and recovery programs, strategies for enhancing physical performance, pre-employment screening tests, assessments of an individual's work capacity, and workplace ergonomic reviews. These offerings are delivered by licensed physical therapists and expert certified athletic trainers to a diverse clientele, including Fortune 500 corporations, insurance providers, and their associated contractors. By the end of 2021, specifically December 31st, the company had established 591 operational clinics across 39 states, in addition to overseeing 35 other physical therapy sites. Established in 1990, the company maintains its headquarters in Houston, Texas.

        CEO
        Christopher J. Reading
        Employees
        7.29K
        Beta
        1.14

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of U.S. Physical Therapy, Inc. (USPH)?

        U.S. Physical Therapy, Inc. (USPH) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is USPH undervalued?

        USPH trades at a price of $95.93 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.